Products with
Antioxidants bioactivity
Cat.No.
|
Product Name
|
BCN1337 |
Methyl 3-hydroxy-4,5-dimethoxybenzoate
|
1. Methyl 3-hydroxy-4,5-dimethoxybenzoate shows obvious antimicrobial activities, the minimum inhibitory concentration of it is 5 mg/ml against Staphylococcus aureus and Rhizopus, and 10 mg/ml against E. coli.
2. Methyl 3-hydroxy-4,5-dimethoxybenzoate shows fairly active for oxidation resistance in the presence of H2O2. |
BCN1428 |
Isomucronulatol
|
1. Isoliquiritigenin and liquiritigenin exhibit significant inhibitory effects on LPS-induced IL-6 and IL-12 p40 production, with IC 50 values ranging from 2.7 to 6.102uM, isoliquiritigenin also shows a moderate inhibitory effect on LPS-stimulated production of TNF-α with an IC 50 value of 20.102 uM, they have potential anti-inflammatory effects.
2. Isomucronulatol exhibits noticeable ABTS+ scavenging activity, it exhibits moderate inhibition against butyrylcholinesterase. |
BCN1522 |
Delphinidin-3,5-O-diglucoside chloride
|
1. Delphinidin-3,5-O-diglucoside chloride has antioxidant activity. |
BCN1527 |
Pelargonidin-3,5-O-diglucoside chloride
|
1. Pelargonidin-3,5-O-diglucoside chloride has antioxidant activity.
2. Pelargonidin-3,5-O-diglucoside chloride has radioprotective effect and the absence of the toxic effect . |
BCN1528 |
Isorhamnetin 3-glucoside-7-rhamnoside
|
1. An anti-oxidative composition containing isorhamnetin-3-glucoside-7-rhamnoside (IGR)isolated from Hippophae rhamnoides L. is provided to ensure antioxidative, antibacterial, and anti-cancer effect; a cosmetic composition for preventing or treating aging contains IGR compound as an active ingredient; a health food composition for antioxiaiton contains IGR as an active ingredient; a pharmaceutical composition for antibacterial and anticancer contains IGR as an active ingredient. |